Virtus Trademark Details
Word Mark | Virtus |
---|---|
Status | Alive 681 — Publication/Issue Review Complete |
Current Owner
Serial Number | 86587871 |
---|---|
Status Date | Wednesday, September 14, 2016 |
Filing Date | Wednesday, September 14, 2016 |
Attorney | Kathleen A. Rheintgen |
Correspondent
Kathleen A. Rheintgen
Husch Blackwell LLP
120 South Riverside Plaza, Suite 2200
Chicago IL 60606
Husch Blackwell LLP
120 South Riverside Plaza, Suite 2200
Chicago IL 60606
Case File Statements
Goods & Services | Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia |
---|---|
Goods & Services | Distributorship services in the field of prescription and over-the-counter drugs; marketing of prescription and over-the-counter drugs |
Goods & Services | Development of pharmaceutical products |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, April 14, 2015 |
First Use Anywhere | Saturday, October 1, 2011 |
First Use In Commerce | Saturday, October 1, 2011 |
Primary Code | 005 |
International Class Codes |
035
|
---|---|
U.S. Class Codes | 100, 101, 102 |
Status | 6 — Active |
Status Date | Tuesday, April 14, 2015 |
First Use Anywhere | Saturday, October 1, 2011 |
First Use In Commerce | Saturday, October 1, 2011 |
Primary Code | 035 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Tuesday, April 14, 2015 |
First Use Anywhere | Saturday, October 1, 2011 |
First Use In Commerce | Saturday, October 1, 2011 |
Primary Code | 042 |
Trademark Timeline
-
Oct 01 2011First use anywhere for the mark
-
Oct 01 2011First use in commerce for the mark
-
Oct 01 2011First use anywhere for the mark
-
Oct 01 2011First use in commerce for the mark
-
Oct 01 2011First use anywhere for the mark
-
Oct 01 2011First use in commerce for the mark
-
Apr 06 2015Trademark application filed with USPTO
-
Apr 09 2015New Application Entered In Tram
-
Apr 14 2015New Application Office Supplied Data Entered In Tram
-
Apr 30 2015Teas Amendment Entered Before Attorney Assigned
-
Apr 30 2015Teas Voluntary Amendment Received
-
Jul 14 2015Assigned To Examiner
-
Jul 20 2015Notification of Non-Final Action E-Mailed
-
Jul 20 2015Non-Final Action E-Mailed
-
Jul 20 2015Non-Final Action Written
-
Jul 21 2015Notification of Non-Final Action E-Mailed
-
Jul 21 2015Non-Final Action E-Mailed
-
Jul 21 2015Non-Final Action Written
-
Jan 20 2016Teas/email Correspondence Entered
-
Jan 20 2016Correspondence Received In Law Office
-
Jan 20 2016Teas Response To Office Action Received
-
Feb 03 2016Notification of Non-Final Action E-Mailed
-
Feb 03 2016Non-Final Action E-Mailed
-
Feb 03 2016Non-Final Action Written
-
Jul 18 2016Attorney Revoked And/or Appointed
-
Jul 18 2016Teas Revoke/appoint Attorney Received
-
Aug 04 2016Teas Response To Office Action Received
-
Aug 04 2016Petition To Revive-Granted
-
Aug 04 2016Teas Petition To Revive Received
-
Aug 05 2016Notice of Revival - E-Mailed
-
Aug 13 2016Assigned To Lie
-
Aug 15 2016Teas/email Correspondence Entered
-
Aug 15 2016Correspondence Received In Law Office
-
Aug 31 2016Examiner's Amendment Entered
-
Aug 31 2016Notification of Examiners Amendment E-Mailed
-
Aug 31 2016Examiners Amendment E-Mailed
-
Aug 31 2016Examiners Amendment -Written
-
Sep 01 2016Approved For Pub - Principal Register
-
Sep 14 2016Law Office Publication Review Completed
-
Sep 28 2016Notification of Notice of Publication E-Mailed